Partner Aaron Tantleff was quoted in a CIO Dive article, “GDPR watchdogs bulk up budgets, but COVID-19 slows investigations,” about the progress the General Protection Data Regulation (GDPR) has made in terms of consumer data privacy rights.
As watchdogs bulk up budgets and staff to respond to more infringements, Tantleff said, a degree of consistency should follow. “Based solely on my own experiences … when a penalty is issued, they are smaller in nature if the organization is the party that alerts the supervisory authority,” as opposed to the authority finding out by other means, he said.
As a result of the GDPR and impending legislation in the U.S., such as the California Consumer Privacy Act, businesses have invested millions in data protection, Tantleff added. “This is an investment that would not have happened but for the GDPR,” he said.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”